Also trades as: QY1.F (FSX) · $vol 0M

$23.94

Last traded 2023-11-14 — delisted

NASDAQ · Healthcare · Medical - Healthcare Information Services · $1.6B mcap · 55M float · 2.25% daily turnover

Revenue

$653M +9.5% ▲

5Y CAGR: +4.2%

Gross Profit

$311M +3.4% ▲

5Y CAGR: +1.5%

Operating Income

$16M +45.8% ▲

5Y CAGR: +41.9%

Net Income

-$3M -264.0% ▼

EPS (Diluted)

$-0.04 -298.0% ▼

EBITDA

$48M -10.1% ▼

5Y CAGR: +76.3%

View Full Income Statement

Line Item	FY2019	FY2020	FY2021	FY2022	FY2023
Revenue	$529M	$540M	$557M	$596M	$653M
YoY Growth	-0.3%	+2.1%	+3.1%	+7.1%	+9.5%
Cost of Revenue	$247M	$267M	$275M	$295M	$342M
Gross Profit	$282M	$273M	$281M	$301M	$311M
Gross Margin	53.4%	50.5%	50.5%	50.5%	47.6%
R&D Expenses	$81M	$83M	$76M	$77M	$82M
SG&A Expenses	$165M	$165M	$181M	$210M	$223M
Operating Expenses	$250M	$253M	$260M	$290M	$309M
Operating Income	$32M	$21M	$21M	$11M	$16M
Operating Margin	6.0%	3.9%	3.8%	1.9%	2.5%
Interest Expense	$3M	$2M	$4M	$1M	$6M
Income Before Tax	$29M	$4M	$9M	$5M	$4M
Tax Expense	$5M	-$3M	-$240K	$4M	$7M
Net Income	$24M	$7M	$10M	$2M	-$3M
Net Margin	4.6%	1.4%	1.7%	0.3%	-0.4%
EPS (Diluted)	$0.38	$0.11	$0.14	$0.02	$-0.04
EBITDA	$38M	$25M	$70M	$53M	$48M
Shares Outstanding	65M	66M	67M	68M	67M

Line Item	FY2022 Q3	FY2022 Q4	FY2023 Q1	FY2023 Q2	FY2023 Q3	FY2023 Q4	FY2024 Q1	FY2024 Q2
Revenue	$150M	$151M	$153M	$159M	$162M	$179M	$178M	$176M
Cost of Revenue	$74M	$76M	$80M	$83M	$85M	$94M	$98M	$95M
Gross Profit	$76M	$75M	$73M	$77M	$77M	$85M	$80M	$82M
Gross Margin	50.4%	49.9%	47.8%	48.2%	47.3%	47.3%	44.8%	46.3%
R&D Expenses	$19M	$19M	$22M	$21M	$20M	$20M	$21M	$18M
SG&A Expenses	$47M	$50M	$49M	$45M	$46M	$83M	$48M	$54M
Operating Expenses	$68M	$70M	$72M	$66M	$67M	$105M	$70M	$73M
Operating Income	$8M	$3M	$1M	$21M	$10M	-$20M	$12M	$8M
Operating Margin	5.3%	1.9%	0.8%	13.0%	5.9%	-11.3%	6.9%	4.6%
Interest Expense	$321K	$541K	$330K	$325K	$2M	$3M	$3M	$3M
Income Before Tax	$8M	$2M	$901K	$19M	$9M	-$25M	$9M	$7M
Tax Expense	$3M	$2M	-$247K	$6M	$1M	$479K	$2M	$2M
Net Income	$5M	$348K	$1M	$14M	$8M	-$25M	$6M	$5M
Net Margin	3.5%	0.2%	0.7%	8.5%	4.8%	-14.1%	3.5%	2.9%
EPS (Diluted)	$0.08	$0.01	$0.02	$0.20	$0.12	$-0.38	$0.09	$0.07
EBITDA	$19M	$13M	$10M	$28M	$20M	-$8M	$22M	$19M
Shares Outstanding	68M	68M	68M	68M	67M	66M	67M	68M

NXGN NASDAQ